Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy

Functional magnetic resonance imaging of covert word generation was used to examine brain activation abnormalities associated with topiramate-induced cognitive language impairment in patients with epilepsy. Compared with a control epilepsy group, in the topiramate-treated group, there was significantly less activation in the language-mediating regions of the prefrontal cortex; the topiramate group also had significantly lower neuropsychological language scores. These findings suggest that topiramate has a critical effect on the cerebral neural systems that mediate expressive language.

[1]  G. McCarthy,et al.  Echo-planar magnetic resonance imaging studies of frontal cortex activation during word generation in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Ojemann,et al.  Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. , 1989, Journal of neurosurgery.

[3]  Josemir W Sander,et al.  Effects of topiramate on cognitive function , 2000, Journal of neurology, neurosurgery, and psychiatry.

[4]  R. Post,et al.  Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. , 1999, Neurology.

[5]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[6]  J. Arends,et al.  Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center , 2004, Epilepsy & Behavior.

[7]  H. Meinardi,et al.  Monotherapy or Polytherapy for Epilepsy Revisited: A Quantitative Assessment , 1995, Epilepsia.

[8]  Jullie W Pan,et al.  Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults , 2002, Neurology.

[9]  G. Morris,et al.  Postmarketing Experience with Topiramate and Cognition , 2001, Epilepsia.

[10]  W. van den Burg,et al.  [Measurements of aphasic disorders. A brief description of the SAN-battery]. , 1980, Gerontologie.

[11]  C. E. Elger,et al.  Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy , 2005, Epilepsy & Behavior.

[12]  Jullie W Pan,et al.  Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults , 1999, Neurology.

[13]  G. Pledger,et al.  A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset Seizures , 2000, Epilepsia.

[14]  A. Aldenkamp,et al.  Newer Antiepileptic Drugs and Cognitive Issues , 2003, Epilepsia.

[15]  Wolfgang Grodd,et al.  Right-Hemispheric Organization of Language Following Early Left-Sided Brain Lesions: Functional MRI Topography , 2002, NeuroImage.

[16]  F. Petty.  GABA and mood disorders: a brief review and hypothesis. , 1995, Journal of affective disorders.

[17]  C. Elger,et al.  Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication , 2004, Epilepsy & Behavior.

[18]  R. Shank,et al.  An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action , 2000, Epilepsia.

[19]  J. Saper,et al.  Topiramate for migraine prevention: a randomized controlled trial. , 2004, JAMA.

[20]  J. Sackellares,et al.  Topiramate Titration and Tolerability , 2001, The Annals of pharmacotherapy.